A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients

Abstract The Steno Diabetes Center Copenhagen developed the Steno T1 Risk Engine (ST1RE) to predict cardiovascular events, encompassing fatal and nonfatal ischemic heart disease, ischemic stroke, heart failure, and peripheral arterial disease in type 1 diabetes mellitus(T1DM). The current study inve...

Full description

Bibliographic Details
Main Authors: Fabiano Malard de Araujo, Fábio Vasconcellos Comim, Rodrigo N. Lamounier, Natália F. Pena, Virgínia C. Fajardo, Regina Bicalho G. de Faria, Yuri M. Silva, Márcio Weissheimer Lauria
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:https://doi.org/10.1186/s13098-023-01224-5
_version_ 1797355679019696128
author Fabiano Malard de Araujo
Fábio Vasconcellos Comim
Rodrigo N. Lamounier
Natália F. Pena
Virgínia C. Fajardo
Regina Bicalho G. de Faria
Yuri M. Silva
Márcio Weissheimer Lauria
author_facet Fabiano Malard de Araujo
Fábio Vasconcellos Comim
Rodrigo N. Lamounier
Natália F. Pena
Virgínia C. Fajardo
Regina Bicalho G. de Faria
Yuri M. Silva
Márcio Weissheimer Lauria
author_sort Fabiano Malard de Araujo
collection DOAJ
description Abstract The Steno Diabetes Center Copenhagen developed the Steno T1 Risk Engine (ST1RE) to predict cardiovascular events, encompassing fatal and nonfatal ischemic heart disease, ischemic stroke, heart failure, and peripheral arterial disease in type 1 diabetes mellitus(T1DM). The current study investigated the agreement between ST1RE and the Brazilian Society for Endocrinology and Metabology (SBEM) classification. Participants were included in the study if diagnosed with T1DM and had at least one outpatient visit in 2021. Patients with established cardiovascular disease and chronic kidney disease on dialysis were excluded. Clinical parameters were obtained from medical records, such as age, body mass index (BMI), blood pressure, physical activity, current smoking, microvascular target organ damage, levels of low-density lipoprotein cholesterol, creatinine, glycated hemoglobin (HbA1c), and albuminuria. Overall, 92 patients (38 males and 53 females) with an age median (P25; P75) of 33 years (25.5;42.5), BMI of 24.8 + 4.1 kg/m2, and duration of diabetes (mean ± SD) of 23.4 + 9.5 years were evaluated. There were no differences considering the gender for most analyzed variables, but a higher proportion of women exhibited microvascular complications such as microalbuminuria, macroalbuminuria, and retinopathy. Our results show a weak agreement in the 10-year cardiovascular risk estimation between SBEM and ST1RE classifications. According to SBEM criteria, 72.8% of patients were considered high-risk, while only 15.2% of patients received the same classification using ST1RE. The dissimilarities between these two classifications were also evident when age and gender factors were compared. While 60% of patients under 35 years were classified as high risk according to SBEM criteria, only 1.8% received this stratification risk in the ST1RE classification. The results indicate a low agreement between the 10-year cardiovascular event risk classification by SBEM and the classification by ST1RE for type 1 diabetes patients without established cardiovascular disease.
first_indexed 2024-03-08T14:14:35Z
format Article
id doaj.art-d749ed9280644eeab3248d9c21f63eee
institution Directory Open Access Journal
issn 1758-5996
language English
last_indexed 2024-03-08T14:14:35Z
publishDate 2024-01-01
publisher BMC
record_format Article
series Diabetology & Metabolic Syndrome
spelling doaj.art-d749ed9280644eeab3248d9c21f63eee2024-01-14T12:30:50ZengBMCDiabetology & Metabolic Syndrome1758-59962024-01-011611710.1186/s13098-023-01224-5A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patientsFabiano Malard de Araujo0Fábio Vasconcellos Comim1Rodrigo N. Lamounier2Natália F. Pena3Virgínia C. Fajardo4Regina Bicalho G. de Faria5Yuri M. Silva6Márcio Weissheimer Lauria7Hospital das Clínicas da Universidade Federal de Minas GeraisUniversidade Federal de Minas GeraisUniversidade Federal de Minas GeraisUniversidade Federal de Minas GeraisUniversidade Federal de Minas GeraisUniversidade Federal de Minas GeraisUniversidade Federal de Minas GeraisUniversidade Federal de Minas GeraisAbstract The Steno Diabetes Center Copenhagen developed the Steno T1 Risk Engine (ST1RE) to predict cardiovascular events, encompassing fatal and nonfatal ischemic heart disease, ischemic stroke, heart failure, and peripheral arterial disease in type 1 diabetes mellitus(T1DM). The current study investigated the agreement between ST1RE and the Brazilian Society for Endocrinology and Metabology (SBEM) classification. Participants were included in the study if diagnosed with T1DM and had at least one outpatient visit in 2021. Patients with established cardiovascular disease and chronic kidney disease on dialysis were excluded. Clinical parameters were obtained from medical records, such as age, body mass index (BMI), blood pressure, physical activity, current smoking, microvascular target organ damage, levels of low-density lipoprotein cholesterol, creatinine, glycated hemoglobin (HbA1c), and albuminuria. Overall, 92 patients (38 males and 53 females) with an age median (P25; P75) of 33 years (25.5;42.5), BMI of 24.8 + 4.1 kg/m2, and duration of diabetes (mean ± SD) of 23.4 + 9.5 years were evaluated. There were no differences considering the gender for most analyzed variables, but a higher proportion of women exhibited microvascular complications such as microalbuminuria, macroalbuminuria, and retinopathy. Our results show a weak agreement in the 10-year cardiovascular risk estimation between SBEM and ST1RE classifications. According to SBEM criteria, 72.8% of patients were considered high-risk, while only 15.2% of patients received the same classification using ST1RE. The dissimilarities between these two classifications were also evident when age and gender factors were compared. While 60% of patients under 35 years were classified as high risk according to SBEM criteria, only 1.8% received this stratification risk in the ST1RE classification. The results indicate a low agreement between the 10-year cardiovascular event risk classification by SBEM and the classification by ST1RE for type 1 diabetes patients without established cardiovascular disease.https://doi.org/10.1186/s13098-023-01224-5Cardiovascular riskType 1 diabetes mellitusSteno calculatorST1RE
spellingShingle Fabiano Malard de Araujo
Fábio Vasconcellos Comim
Rodrigo N. Lamounier
Natália F. Pena
Virgínia C. Fajardo
Regina Bicalho G. de Faria
Yuri M. Silva
Márcio Weissheimer Lauria
A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients
Diabetology & Metabolic Syndrome
Cardiovascular risk
Type 1 diabetes mellitus
Steno calculator
ST1RE
title A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients
title_full A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients
title_fullStr A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients
title_full_unstemmed A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients
title_short A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients
title_sort comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients
topic Cardiovascular risk
Type 1 diabetes mellitus
Steno calculator
ST1RE
url https://doi.org/10.1186/s13098-023-01224-5
work_keys_str_mv AT fabianomalarddearaujo acomparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT fabiovasconcelloscomim acomparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT rodrigonlamounier acomparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT nataliafpena acomparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT virginiacfajardo acomparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT reginabicalhogdefaria acomparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT yurimsilva acomparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT marcioweissheimerlauria acomparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT fabianomalarddearaujo comparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT fabiovasconcelloscomim comparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT rodrigonlamounier comparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT nataliafpena comparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT virginiacfajardo comparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT reginabicalhogdefaria comparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT yurimsilva comparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients
AT marcioweissheimerlauria comparativestudyofcardiovascularriskstratificationmethodsintype1diabetesmellituspatients